Patrick Taylor Horn - 18 Mar 2024 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Chief Medical Officer
Signature
/s/ Greg Tourangeau as attorney-in-fact for Patrick Horn
Issuer symbol
FULC
Transactions as of
18 Mar 2024
Net transactions value
$0
Form type
4
Filing time
20 Mar 2024, 16:15:10 UTC
Previous filing
25 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +400,000 $0.000000 400,000 18 Mar 2024 Common Stock 400,000 $10.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on March 18, 2024 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of March 18, 2024. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.